Device and drug trials pose a variety of challenges; they are, after all, completely different in study design, have varying regulatory pathways, as well as differing executional challenges. In this interview, Tony Fiorino, Chief Medical Officer of electroCore, will discuss challenges he has faced with device studies, and will elaborate on his experiences about the differences between device and drug trials.
The Differences Between Device and Drug Studies
By Michael Tattory|
2019-06-19T12:33:52-04:00
June 18th, 2019|News|Comments Off on The Differences Between Device and Drug Studies